149 related articles for article (PubMed ID: 32853710)
1. Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study.
Vittrup AS; Tanderup K; Bentzen SM; Jensen NBK; Spampinato S; Fokdal LU; Lindegaard JC; Sturdza A; Schmid M; Segedin B; Jürgenliemk-Schulz IM; Bruheim K; Mahantshetty U; Haie-Meder C; Rai B; Cooper R; van der Steen-Banasik E; Sundset M; Huang F; Nout RA; Villafranca E; Van Limbergen E; Pieters BR; Tan LT; Lutgens LCHW; Hoskin P; Pötter R; Kirchheiner K;
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):161-173. PubMed ID: 32853710
[TBL] [Abstract][Full Text] [Related]
2. Late, Persistent, Substantial, Treatment-Related Symptoms After Radiation Therapy (LAPERS): A New Method for Longitudinal Analysis of Late Morbidity-Applied in the EMBRACE Study.
Kirchheiner K; Pötter R; Nout RA; Schwartz-Vittrup A; Holzner B; Bentzen SM; Tanderup K
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):300-309. PubMed ID: 31669565
[TBL] [Abstract][Full Text] [Related]
3. Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study.
K Jensen NB; Pötter R; Spampinato S; Fokdal LU; Chargari C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Wiebe E; Cooper R; Van der Steen-Banasik E; Van Limbergen E; Sundset M; Pieters BR; Nout RA; Kirisits C; Kirchheiner K; Tanderup K;
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):688-700. PubMed ID: 33068689
[TBL] [Abstract][Full Text] [Related]
4. Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer.
Fokdal L; Pötter R; Kirchheiner K; Lindegaard JC; Jensen NBK; Kirisits C; Chargari C; Mahantshetty U; Jürgenliemk-Schulz IM; Segedin B; Hoskin P; Tanderup K
Radiother Oncol; 2018 Jun; 127(3):423-430. PubMed ID: 29784450
[TBL] [Abstract][Full Text] [Related]
5. Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study.
Jensen NBK; Pötter R; Kirchheiner K; Fokdal L; Lindegaard JC; Kirisits C; Mazeron R; Mahantshetty U; Jürgenliemk-Schulz IM; Segedin B; Hoskin P; Tanderup K;
Radiother Oncol; 2018 Jun; 127(3):431-439. PubMed ID: 29880222
[TBL] [Abstract][Full Text] [Related]
6. Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study.
Najjari Jamal D; Pötter R; Haie-Meder C; Lindegaard JC; Juergenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Wiebe E; Cooper R; Tanderup K; Kirchheiner K;
Radiother Oncol; 2018 Jun; 127(3):449-455. PubMed ID: 29631933
[TBL] [Abstract][Full Text] [Related]
7. Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study.
Smet S; Pötter R; Haie-Meder C; Lindegaard JC; Schulz-Juergenliemk I; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Huang F; Cooper R; van Limbergen E; Tanderup K; Kirchheiner K;
Radiother Oncol; 2018 Jun; 127(3):440-448. PubMed ID: 29627137
[TBL] [Abstract][Full Text] [Related]
8. Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future.
Spampinato S; Jensen NBK; Pötter R; Fokdal LU; Chargari C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Hoskin P; Segedin B; Rai B; Bruheim K; Wiebe E; Van der Steen-Banasik E; Cooper R; Van Limbergen E; Sundset M; Pieters BR; Lutgens LCHW; Tan LT; Villafranca E; Smet S; Jastaniyah N; Nout RA; Kirisits C; Chopra S; Kirchheiner K; Tanderup K; Embrace Collaborative Group
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):681-693. PubMed ID: 34678431
[TBL] [Abstract][Full Text] [Related]
9. Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
Kirchheiner K; Pötter R; Tanderup K; Lindegaard JC; Haie-Meder C; Petrič P; Mahantshetty U; Jürgenliemk-Schulz IM; Rai B; Cooper R; Dörr W; Nout RA;
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1088-98. PubMed ID: 26876955
[TBL] [Abstract][Full Text] [Related]
10. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Westerveld H; Haie-Meder C; Petrič P; Mahantshetty U; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):88-95. PubMed ID: 24725693
[TBL] [Abstract][Full Text] [Related]
11. Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis.
Pelizzola M; Tanderup K; Chopra S; Jürgenliemk-Schulz IM; Nout R; Kirchheiner K; Spampinato S
Acta Oncol; 2023 Nov; 62(11):1479-1487. PubMed ID: 37906286
[TBL] [Abstract][Full Text] [Related]
12. Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis.
Spampinato S; Fokdal LU; Pötter R; Haie-Meder C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Huang F; Cooper R; van der Steen-Banasik E; Van Limbergen E; Sundset M; Westerveld H; Nout RA; Jensen NBK; Kirisits C; Kirchheiner K; Tanderup K;
Radiother Oncol; 2021 May; 158():300-308. PubMed ID: 33065183
[TBL] [Abstract][Full Text] [Related]
13. Early morbidity and dose-volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques.
Seppenwoolde Y; Majercakova K; Buschmann M; Dörr E; Sturdza AE; Schmid MP; Pötter R; Georg D
Strahlenther Onkol; 2021 Jun; 197(6):505-519. PubMed ID: 33929558
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis.
Spampinato S; Fokdal LU; Pötter R; Haie-Meder C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Huang F; Cooper R; van der Steen-Banasik E; Van Limbergen E; Sundset M; Westerveld H; Nout RA; Jensen NBK; Kirisits C; Kirchheiner K; Tanderup K;
Radiother Oncol; 2021 May; 158():312-320. PubMed ID: 33545254
[TBL] [Abstract][Full Text] [Related]
15. Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Vittrup AS; Kirchheiner K; Pötter R; Fokdal LU; Jensen NBK; Spampinato S; Haie-Meder C; Schmid MP; Sturdza AE; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Wiebe E; van der Steen-Banasik E; Cooper R; Van Limbergen E; Sundset M; Pieters BR; Kirisits C; Lindegaard JC; Jürgenliemk-Schulz IM; Nout R; Tanderup K;
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):807-824. PubMed ID: 36641039
[TBL] [Abstract][Full Text] [Related]
16. Health related quality of life and patient reported symptoms before and during definitive radio(chemo)therapy using image-guided adaptive brachytherapy for locally advanced cervical cancer and early recovery - a mono-institutional prospective study.
Kirchheiner K; Nout RA; Czajka-Pepl A; Ponocny-Seliger E; Sturdza AE; Dimopoulos JC; Dörr W; Pötter R
Gynecol Oncol; 2015 Mar; 136(3):415-23. PubMed ID: 25462202
[TBL] [Abstract][Full Text] [Related]
17. Late, persistent, substantial treatment-related symptoms (LAPERS) following low-dose-rate brachytherapy for prostate cancer.
Ong WL; Millar J
Brachytherapy; 2023; 22(4):524-530. PubMed ID: 36707331
[TBL] [Abstract][Full Text] [Related]
18. Initiatives for education, training, and dissemination of morbidity assessment and reporting in a multiinstitutional international context: Insights from the EMBRACE studies on cervical cancer.
Kirchheiner K; Smet S; Spampinato S; Jensen NBK; Vittrup AS; Fokdal L; Najjari-Jamal D; Westerveld HG; Lindegaard JC; Kirisits C; De Leeuw A; Schmid MP; Tan LT; Nout RA; Jürgenliemk-Schulz IM; Pötter R; Tanderup K;
Brachytherapy; 2020; 19(6):837-849. PubMed ID: 32978080
[TBL] [Abstract][Full Text] [Related]
19. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors.
Spampinato S; Tanderup K; Lindegaard JC; Schmid MP; Sturdza A; Segedin B; Jürgenliemk-Schulz IM; De Leeuw A; Bruheim K; Mahantshetty U; Chargari C; Rai B; Cooper R; van der Steen-Banasik E; Sundset M; Wiebe E; Villafranca E; Van Limbergen E; Pieters BR; Tee Tan L; Lutgens LCHW; Hoskin P; Smet S; Pötter R; Nout R; Chopra S; Kirchheiner K;
Radiother Oncol; 2023 Apr; 181():109501. PubMed ID: 36720348
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies.
Fokdal L; Tanderup K; Pötter R; Sturdza A; Kirchheiner K; Chargari C; Jürgenliemk-Schulz IM; Segedin B; Tan LT; Hoskin P; Mahantshetty U; Bruheim K; Rai B; Kirisits C; Lindegaard JC;
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):887-894. PubMed ID: 30419309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
